Mesalazine didn’t help diarrhea-predominant IBS

CHICAGO – Treating diarrhea-predominant irritable bowel syndrome with mesalazine for 12 weeks failed to improve stool frequency or other symptoms, compared with placebo, in a multicenter, randomized...

Field of Interest: Gastroentero...
Type: News Item

Statins linked to lower physical activity

Initiating statin therapy in older men was associated with a modest but significant drop in physical activity, according findings from a large, observational study published online June 9 in JAMA...

Field of Interest: Gastroentero...
Type: News Item

Azathioprine, anti-TNF monotherapy safe in IBD pregnancy

CHICAGO – Women with inflammatory bowel disease can safely continue monotherapy with azathioprine/6-mercaptopurine or antitumor necrosis–alpha agents during pregnancy to maintain remission, according...

Field of Interest: Pulmonology
Type: News Item

Tests may help before liver transplant, not after

CHICAGO – Two laboratory measurements that are commonly used to assess the cause of symptomatic ascites before liver transplant may be deceptive when used to assess posttransplant ascites, a...

Field of Interest: Gastroentero...
Type: News Item

Phone calls offer ‘early warning’ in IBD

Inflammatory bowel disease patients rely on phone communication as much as or more than doctor visits for management of their disease, and heavier reliance may be a sign of impending emergency...

Field of Interest: Gastroentero...
Type: News Item

Ramosetron offers IBS-D alternative

Once-daily ramosetron improved stool consistency in male patients with diarrhea-predominant irritable bowel syndrome, Dr. Shin Fukudo and colleagues reported in the June issue of Clinical...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness